Related references
Note: Only part of the references are listed.A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
A. Gringeri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors
L. A. Valentino
HAEMOPHILIA (2010)
Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series
C. Escuriola Ettingshausen et al.
HAEMOPHILIA (2010)
The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series
L. A. Valentino
HAEMOPHILIA (2009)
Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations
V. Jimenez-Yuste et al.
HAEMOPHILIA (2009)
Intracranial haemorrhage in haemophilia A and B
Rolf C. R. Ljung
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Intracranial bleeding in haemophilia beyond the neonatal period - the role of CT imaging in suspected intracranial bleeding
C. Traivaree et al.
HAEMOPHILIA (2007)
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
B. A. Konkle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Marilyn J. Manco-Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prophylactic treatment with activated prothrombin complex concentrate (FEIBA®) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors
C. A. Leissinger et al.
HAEMOPHILIA (2007)
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study
Jan Astermark et al.
BLOOD (2007)
Surgical excision of a giant pelvic pseudotumour in a patient with haemophilia A
L. A. Valentino et al.
HAEMOPHILIA (2006)
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors
L Scalone et al.
HAEMOPHILIA (2006)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of intracranial bleeds on the health and quality of life of boys with hemophilia
S Revel-Vilk et al.
JOURNAL OF PEDIATRICS (2004)
The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99
SC Darby et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Prevention of bleeds in hemophilia patients with inhibitors: Emerging data and clinical direction
CA Leissinger
AMERICAN JOURNAL OF HEMATOLOGY (2004)
The economic impact of factor VIII inhibitors in patients with haemophilia
RL Bohn et al.
HAEMOPHILIA (2004)
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group
A Gringeri et al.
BLOOD (2003)
Intracranial haemorrhage among a population of haemophilic patients in Brazil
SV Antunes et al.
HAEMOPHILIA (2003)
Long-term FEIBA prophylaxis does not prevent progression of existing joint disease
MW Hilgartner et al.
HAEMOPHILIA (2003)
Inhibitors: resolving diagnostic and therapeutic dilemmas
D Dimichele
HAEMOPHILIA (2002)
Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage
R Nuss et al.
AMERICAN JOURNAL OF HEMATOLOGY (2001)
Share Paper
